Supply Chain

The Food and Drug Administration recently approved Sanofi's new type 2 diabetes treatment Soliqua.

Plainsboro, N.J.-based Novo Nordisk recently earned Food and Drug Administration approval for its Type 2 diabetes treatment Xultophy.

The Food and Drug Administration will wait until members of the next White House administration and Congress take office before finalizing guidance on laboratory developed tests.

Gartner recently released is eighth annual Healthcare Supply Chain Top 25 rankings.

Premier recently released the results of its semiannual economic outlook survey, which polls healthcare executives on the biggest issues facing their supply chains and health systems.

DHL Express plans to spend $185 million to add new infrastructure, technology and workers to its U.S. operations over the next year, according to DC Velocity.

The Centers for Medicare & Medicaid Services' move to expand episode-based payments—and employers' strong interest in bundled payments for high-cost chronic conditions1—mean that bundled payments are expected to become the norm.

Here are the six latest drugs or medical devices approved by the Food and Drug Administration.

The Food and Drug Administration recently approved Intrarosa as a treatment for women who experience dyspareunia, or moderate to severe pain during sexual intercourse.

Somerset, N.J.-based Gavis Pharmaceuticals — a subsidiary of Mumbai-based Lupin Limited — recently earned approval from the Food and Drug Administration for its hydrocodone bitartrate and acetaminophen tablets.